Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-000502

CHIEF EXECUTIVE OFFICER gave up 643 shares (to pay taxes)

  • CHIEF EXECUTIVE OFFICER acquired 1,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Williams Gregory C. · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-30 Exercise or conversion : show line 1 in the form +1,875 10,632 D
2021-01-30 Shares withheld for taxes : show line 2 in the form −643 $3.44 $2,212 9,989 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,875 15,000 D
Loading xslF345X03/form4-02022021_040206.xml…